Free Trial
OTCMKTS:PCYN

Procyon (PCYN) Stock Price, News & Analysis

$0.20 0.00 (0.00%)
(As of 12/20/2024 ET)

About Procyon Stock (OTCMKTS:PCYN)

Key Stats

Today's Range
$0.20
$0.20
50-Day Range
$0.19
$0.25
52-Week Range
$0.17
$0.34
Volume
N/A
Average Volume
7,760 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. It provides advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. The company also offers Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; and rolled gauze wound care kits. In addition, it provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. Further, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products, as well as retention tapes; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE brand name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.

Receive PCYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Procyon and its competitors with MarketBeat's FREE daily newsletter.

PCYN Stock News Headlines

TTHG Titanium Holdings Group, Inc.
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Procyon Corporation (PCYN)
Procyon Corp. - New (PCYN)
Procyon Corp.
See More Headlines

PCYN Stock Analysis - Frequently Asked Questions

Procyon's stock was trading at $0.1705 at the beginning of 2024. Since then, PCYN stock has increased by 17.9% and is now trading at $0.2010.
View the best growth stocks for 2024 here
.

Shares of PCYN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Procyon investors own include Curaleaf (CURLF), California Republic Bancorp (CRPB), Aphria (APHA), Aerie Pharmaceuticals (AERI), McEwen Mining (MUX), Discovery Silver (DSV) and Digital Ally (DGLY).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PCYN
CUSIP
742806300
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (OTCMKTS:PCYN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners